CareLit Fachartikel
The Use of Autologous Stem Cells in the Rehabilitation of Multiple Sclerosis
GH Kraft · Physikalische Medizin Rehabilitationsmedizin Kurortmedizin · 2015 · Heft 06
Dokument
1145337
CareLit-ID
Jahr
2015
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig
Bibliografische Angaben
Zusammenfassung
Prior to 1993 there were no disease-modifying therapies (DMTs) for multiple sclerosis (MS). Rehabilitative techniques were the only available methods for managing this disease. [1] We used these techniques to substitute for progressive neurological loss and maintain function. In the fall of 1993 the first DMT for MS was approved by the U.S. FDA, and over the years since then more than a dozen increasingly efficacious DMTs have become available on the U.S. market. However, at best these DMTs offer only partial disease control; patients will typically continue to get worse. It has been known for some time that MS…
Schlagworte
Blood
Transplantation
Treatment Failure
Cyclophosphamide
Carmustine
Counseling
Cytarabine
Depression
Employment
Workplace
AIDS
Physikalische Medizin Rehabilitationsmedizin Kurortmedizin
